12:00 AM
 | 
Mar 26, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Quest Diagnostics, Beth Israel Deaconess Medical Center (BIDMC), Weill Cornell Medical College sales and marketing update

Quest launched a molecular blood test in the U.S. to identify kidney transplant rejection. The test includes RNA genetic markers...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >